Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Magnetic Resonance Imaging Assessment of Cardiac and Liver Iron Load in Patients With Haemoglobinopathies, Myelodysplastic Syndromes (MDS) or Other Anaemias Treated With Exjade® (Deferasirox) (The MILE Study)

NCT00673608 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00673608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00673608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Magnetic Resonance Imaging Assessment of Cardiac and Liver Iron Load in Patients With Haemoglobinopathies, Myelodysplastic Syndromes (MDS) or Other Anaemias Treated With Exjade® (Deferasirox) (The MILE Study)
Lead sponsor
Novartis
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2007
Completion date
September 30, 2011
Enrollment
118 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

diamond-blackfan anemia, hemoglobinopathies, mpd syndrome, myelodysplastic syndromes, other inherited or acquired anaemia, other rare anaemias, transfusional iron overload